Skip to content

Clinical observation of Shexiang Baoxin Pill combined with cardiac rehabilitation on heart failure patients with preserved ejection fraction

Clinical observation of Shexiang Baoxin Pill combined with cardiac rehabilitation on heart failure patients with preserved ejection fraction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054322
Enrollment
Unknown
Registered
2021-12-13
Start date
2021-12-22
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

group A:Shexiang Baoxin Pill + Cardiac Rehabilitation
group B:Cardiac Rehabilitation

Sponsors

Ruian Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 40-80 years; 2. Cardiac ultrasound EF value >= 50%; 3. Meet the diagnostic criteria for diastolic heart failure in the 'Expert Consensus on Diagnosis and Treatment of Diastolic Heart Failure (2020)'; 4. Willing to follow the protocol for follow-up and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Tracheal intubation is required on admission and mechanical ventilation is required for at least 24 hours; 2. Acute myocardial infarction on admission; 3. Transfer to cardiovascular surgery before receiving rehabilitation treatment; 4. Due to comorbidities, it is not suitable for early recovery; 5. Acute coronary syndrome; severe aortic stenosis; end-stage heart failure; functional status limited by conditions other than acute heart failure; end-stage chronic kidney disease; 6. Terminal illness other than heart failure; 7. Actively participate in supervised exercise training prior to hospitalization.

Design outcomes

Primary

MeasureTime frame
Cardiopulmonary exercise test evaluation;Cardiac ultrasound assessment;Evaluation of carotid femoral pulse wave velocity;

Secondary

MeasureTime frame
Assessment of the International Physical Activity Scale;6-min walking distance test;Quality of life assessment;

Countries

China

Contacts

Public ContactGuan Xiafei
305248098@qq.com+86 13587575702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026